HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient seizure activity demonstrated by Tc-99m HMPAO SPECT and diffusion-weighted MR imaging.

Abstract
Cerebral perfusion single photon emission computed tomography (SPECT) has been used to confirm the localization of the epileptic focus and the evaluation of seizure. Recently, diffusion-weighted MR imaging (DWI) has been recognized for evaluation of seizure activity. We describe a case of transient seizure activity demonstrated by Tc-99m HMPAO SPECT and DWI. This patient was a 61-year-old woman with a 10-month history of right middle cerebral artery (MCA) infarction who had a generalized seizure during MRI. DWI immediately after seizure showed transient hyperintensity in the right frontal gray matter and the white matter, and these apparent diffusion coefficients (ADC) were transiently decreased. This transient hyperintensity on DWI corresponded to transient hyperperfusion identifying the epileptic focus on interictal Tc-99m HMPAO SPECT. Transient sustained seizure activity might cause these changes on DWI and SPECT. It was considered that interictal Tc-99m HMPAO SPECT showed the delayed hyperperfusion caused by excitatory neuronal overaction and DWI showed cytotoxic edema seizure-induced by energy failure of the membrane-bound Na/K-ATPase pump.
AuthorsT Sagiuchi, K Ishii, Y Asano, Y Aoki, R Woodhams, H Yanaihara, S Kan, K Hayakawa
JournalAnnals of nuclear medicine (Ann Nucl Med) Vol. 15 Issue 3 Pg. 267-70 (Jun 2001) ISSN: 0914-7187 [Print] Japan
PMID11545200 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Technetium Tc 99m Exametazime
Topics
  • Cerebral Infarction (diagnosis, diagnostic imaging)
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Paresis (diagnosis, diagnostic imaging)
  • Radiopharmaceuticals
  • Seizures (diagnosis, diagnostic imaging, etiology)
  • Technetium Tc 99m Exametazime
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: